×

Contact Us

For all patient inquiries, please contact your practice location. For all HR, accounting and admin inquiries, please contact us using the link below:

UHA Headquarters
7999 Gateway Blvd., Suite 200 Newark, CA 94560

EMAIL US

Accountable Care Organization

ACO Public Reporting

ACO Name & Location
UHA ACO LLC
7979 Gateway Blvd.
Suite 120
Newark, CA 94560

ACO Primary Contact
Primary Contact Name:  Soumya Mamidala
Primary Contact Phone Number:  510-662-5811
Primary Contact Email Address:  SMamidala@stanfordhealthcare.org

ACO Participants
University HealthCare Alliance
ACO Participant in Joint Venture:  No

ACO Governing Body
Member Last Name Member First Name Member Title/
Position
Member (%) Voting Power Membership Type Legal Business Name/DBA
Krna Catherine Member, Interim Board Chair 30% ACO Participant Representative University Healthcare Alliance
Sankary Richard Member (MD) 30% ACO Participant Representative University Healthcare Alliance
Woods George Medicare Beneficiary (MD) 10% Medicare Beneficiary N/A
Kim Michael Interim Member

 

30% ACO Participant Representative University Healthcare Alliance
Key ACO Clinical and Administrative Leadership
David Overton ACO Executive
Michael Kim, MD Medical Director
Michael O’Connell Compliance Officer
David Overton Quality Assurance/Improvement Officer

 

Associated Committees and Committee Leadership
Committee Name Committee Leader Name and Position
Quality Assurance and
Utilization Management
Michael Kim, MD, Co-Chair
David Overton, RN, Co-Chair
Finance and Cost Analysis Michael Weatherford, Chair

Types of ACO participants, or combinations of participants, that formed the ACO:
ACO Professionals in group practice arrangements

Shared Savings & Losses

Amount of Shared Savings/Losses

  • First Agreement Period
    • Performance Year 2020 – $12,990,026.32
    • Performance Year 2019 – $1,918,033

Shared Savings Distribution

  • First Agreement Period
    • Performance Year 2020
      • Proportion invested in infrastructure: 75%
      • Proportion invested in redesigned care processes/resources: 25%
      • Proportion of distribution to ACO participants: 0%
    • Performance Year 2019
      • Proportion invested in infrastructure: 50%
      • Proportion invested in redesigned care processes/resources: 50%
      • Proportion of distribution to ACO participants: 0%

Quality Performance Results

2020 Quality Performance Results

ACO # Measure Name Rate ACO Mean
ACO-8 Risk Standardized, All Condition Readmission 14.11 15.07
ACO-38 Risk Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions 40.91 49.50
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) 0.51 0.95
ACO-13 Falls: Screening for Future Fall Risk 83.09 84.97
ACO-14 Preventive Care and Screening: Influenza Immunization 90.68 76.03
ACO-17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 94.74 81.67
ACO-18 Preventive Care and Screening: Screening for Depression and Follow-Up Plan 79.27 71.46
ACO-19 Colorectal Cancer Screening 77.10 72.59
ACO-20 Breast Cancer Screening 78.15 74.05
ACO-42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 84.77 83.37
ACO-40 Depression Remission at Twelve Months 5.97 13.99
ACO-27 Diabetes Mellitus: Hemoglobin A1c Poor Control 11.14 14.70
ACO-28 Hypertension (HTN): Controlling High Blood Pressure 65.44 72.87

 

For previous years’ financial and quality performance results, please visit data.cms.gov.

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.

Beneficiary Information Notice
Click here to print the Beneficiary Information Notice from your Primary Care Provider (PCP).

If you are a beneficiary and would like information about MSSP, please call:

  • 1-800-MEDICARE (1-800-633-4227)
  • Teletypewriter users, please call 1-877-486-2048